ENL
Enlitic Inc.
π¦πΊ ASX
π©Ί HEALTH CARE
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-123.35%
Growth
9 months growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
0
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Enlitic, Inc. provides diagnostic healthcare services. The company is headquartered in Fort Collins, Colorado. The company went IPO on 2023-12-19. Enlitic Curie is the Company's foundational platform that uses AI to unlock the value of the customer's data in real time. ENDEX, the Company's software application powered by the Curie platform, improves every aspect of workflow for radiologists. ENDEX conforms health system data to consistent clinical standards, enables relevant linkage across different care systems, uses AI to create hanging protocol displays, improves image routing and orchestration, and automatically standardizes DICOM descriptions before transmission to PACS. The firm's product consists of standarization, anonymization, and real-world evidence (RWE) database.
π Performance
Price History
-93.25%
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
0%
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.06
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in ENL
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in ENL
N/A
ENL investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in ENL also invest in...
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
12.26%
π Share price
$126.57 AUD
π GLOBAL
π€ TECHNOLOGY
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
3.85%
π Share price
$102.89 AUD
π¦πΊ AUSTRALIA
πΈ FINANCIALS
𧱠MATERIALS
β³οΈ DIVERSIFIED
Want more shares? Try these...
Elanor Investors Group engages in providing investment and funds management services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2014-07-11. The company is focused on acquiring and unlocking value in real estate assets to deliver superior risk-adjusted returns for its capital partners. Its segments include Funds Management, Hotels, Tourism and Leisure, Retail, Commercial Office and Healthcare. The Fund Management segment manages third-party owned investment funds and syndicates. Hotels, Tourism and Leisure segment originates and manages investment and fund management assets. The Retail segment originates and manages investment and fund management assets in the retail real estate sector. Commercial Office segment originates and manages investment and fund management assets in the commercial office real estate sector. Healthcare segment originates and manages investment and fund management assets in the healthcare real estate sector. Its investment portfolio includes Elanor Commercial Property Fund, Hunters Plaza Syndicate, 1834 Hospitality, and others.
π Performance (5Yr p.a)
-12.23%
π Share price
$0.82 AUD
π¨ HOTELS, RESTAURANTS & LEISURE
Encounter Resources Ltd. engages in the provision of mineral exploration. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-03-24. The firm is focused on discovering major copper and niobium/ rare earth element (REE) deposits in Australia. The company controls a portfolio of 100% owned projects in Australia's exciting mineral provinces that are prospective for copper and critical minerals. The company has numerous large scale copper projects being advanced in partnership and funded through farm-in agreements with miners: South32 and IGO. Its projects include Aileron Critical Minerals Project, Sandover Copper Project, Beetaloo Basin Copper Projects, Junction Lithium Project, Irwin REE Projects, Lamil Copper-Gold Project, Jessica and Carrara Copper-Zinc Projects, Yeneena Copper Project and Elliott Copper Project. The 100% owned Aileron project covers around 1,765 square kilometers and is located in the West Arunta region of Western Australia. The Jessica and Carrara projects are being explored in partnership with South32 under farm-in agreements.
π Performance (5Yr p.a)
49.60%
π Share price
$0.42 AUD
π HIGH PRICE GROWTH
βοΈ MINING
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-12-13. The firm is engaged in the research and development of medical imaging and diagnostic technology (the EMVision Technology), for the purpose of commercializing a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs. The firm is developing and commercializing medical imaging diagnostics for various disease states and medical emergencies. The Companyβs product pipeline includes portable, non-invasive, neuroimaging devices. Its lead product in development includes a portable, non-ionizing brain scanner, capable of producing images of biological tissue to provide insights for clinicians. Its second-generation device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location.
π Performance (5Yr p.a)
53.51%
π Share price
$2.04 AUD
π©Ί HEALTH CARE
EMXC.AX was created on 2024-06-07 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investors with the performance of an index, before fees and expenses.
π Share price
$26.40 AUD
π¦πΊ EX AUSTRALIA